The National Cancer Institute (NCI) invites applications on the development of novel image acquisition or enhancement methods, incorporating limited pilot or feasibility evaluations using either pre-clinical models or clinical studies. This initiative is intended to facilitate the development of novel imaging technologies for early detection, screening, diagnosis and image guided treatment of cancer and other diseases. The intent is to stimulate: (a) the development of highly innovative image acquisition and enhancement methods, including high risk/high gain research on technologies that exploit our knowledge of the molecular basis of cancer or other disease, and (b) the integration of these emerging technologies with traditional imaging methods for more effective solutions for health care delivery. A phased innovation award mechanism (R21/R33) is proposed that is more suitable for supporting imaging technology development. Applications from academia, industry and the use of the SBIR/STTR funding mechanisms are encouraged.

• Release Date: April 27, 2000
• Letter of Intent Receipt Date(s): June 14, 2000 and February 9, 2001
• Application Receipt Date(s): July 19, 2000 and March 16, 2001
• No set aside
• Contacts:
• Barbara Y. Croft, Ph.D. (bc129b@nih.gov) at 301-496-9531
• Laurence P. Clarke, Ph.D. (lclarke@mail.nih.gov) at 301-496-9531

See full description in NIH Guide: PAR-00-090